Pharmaceutical firms see operating profit plunge in 2011

Published: 2012-04-24 07:00:00

Updated: 2012-04-24 07:00:00

Most of Korea's drug makers saw their earnings fall last year amid dramatic changes in the business environment such as regulations by the government and intense competition among generic drugs, data showed Monday.

The combined sales of 110 drug firms (55 listed firms and 50 unlisted firm on S...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK